ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41895
0.00%
Bitcoin
97,578.73
-0.02%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Oncocyte Corporation (OCX) Share Price

Oncocyte Corporation

Oncocyte Corporation (OCX)

NASDAQ
2.56
0.18
(7.56%)
Closed February 15 3:00PM
Delayed by 15 minutes
2.52
-0.04
(-1.56%)
After Hours: 6:59PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.56
Bid
2.50
Ask
2.59
Volume
73,948
2.35 Day's Range 2.57
1.922 52 Week Range 3.4799
Market Cap
43.098M
Previous Close
2.38
Open
2.35
Last Trade
41
@
2.48
Last Trade Time
Financial Volume
US$ 184,288
VWAP
2.4921
Average Volume (3m)
94,540
Shares Outstanding
16,835,247
Dividend Yield
-
PE Ratio
-1.48
Earnings Per Share (EPS)
-1.71
Revenue
7.27M
Net Profit
-28.72M

About Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
www.oncocyte.com
Headquarters
Irvine, California, USA
Founded
-
Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was US$2.38. Over the last year, Oncocyte shares have traded in a share price range of US$ 1.922 to US$ 3.4799.

Oncocyte currently has 16,835,247 shares outstanding. The market capitalization of Oncocyte is US$40.07 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.48.

Ask ADVFN Intelligence (AI)

OCX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 11 2025
OCX (7.56%)

Form 8-K - Current report
Edgar (US Regulatory)
February 10 2025
OCX (7.56%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
February 10 2025
OCX (7.56%)

Form 8-K - Current report
Edgar (US Regulatory)
January 08 2025
OCX (7.56%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 09 2024
OCX (7.56%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4823.07692307692.082.61.9451575162.37975564CS
40.4320.18779342722.132.61.922893662.21907875CS
12-0.09-3.396226415092.652.79851.922945402.30927152CS
26-0.46-15.23178807953.023.341.922615772.51231859CS
52-0.3-10.48951048952.863.47991.922550822.6582004CS
156-29.84-92.098765432132.433.61.92221896113.02389379CS
260-67.24-96.332378223569.81251.92230218443.11402799CS

OCX - Frequently Asked Questions (FAQ)

What is the current Oncocyte share price?
The current share price of Oncocyte is US$ 2.56
How many Oncocyte shares are in issue?
Oncocyte has 16,835,247 shares in issue
What is the market cap of Oncocyte?
The market capitalisation of Oncocyte is USD 40.07M
What is the 1 year trading range for Oncocyte share price?
Oncocyte has traded in the range of US$ 1.922 to US$ 3.4799 during the past year
What is the PE ratio of Oncocyte?
The price to earnings ratio of Oncocyte is -1.48
What is the cash to sales ratio of Oncocyte?
The cash to sales ratio of Oncocyte is 5.84
What is the reporting currency for Oncocyte?
Oncocyte reports financial results in USD
What is the latest annual turnover for Oncocyte?
The latest annual turnover of Oncocyte is USD 7.27M
What is the latest annual profit for Oncocyte?
The latest annual profit of Oncocyte is USD -28.72M
What is the registered address of Oncocyte?
The registered address for Oncocyte is 15 CUSHING, IRVINE, CALIFORNIA, 92618
What is the Oncocyte website address?
The website address for Oncocyte is www.oncocyte.com
Which industry sector does Oncocyte operate in?
Oncocyte operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
US$ 6.02
(133.33%)
101.64M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
WRDWeRide Inc
US$ 31.4877
(83.39%)
20.57M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.67M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
134.88M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
US$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
189.56M

Discussion

View Full Feed
arizona1 arizona1 4 minutes ago
Not sure what you meant there....

That's exactly how we feel about your constant incomprehensible psychobabble. You never make any sense. You just talk because you're proud that you're a better speller than most MAGAts.
oldstocks oldstocks 5 minutes ago
Digital Spain Development
https://espanadigital.gob.es/en/implementation-agenda
AFFU
newmedman newmedman 5 minutes ago
[yt]0Txp8B4ek_kk9[/yt]
condor1 condor1 6 minutes ago
March 15th is when the equipment from China is scheduled/ supposed to arrive, stated by CT, indicated an updated video to investors. time to set up equipment, operate/test, and turn on full operation, AND THEN revenue recognition later in a couple of months
AABB
stockprofitter stockprofitter 6 minutes ago
There has been such silence I’m not sure he is taking the position.
FNMA
CR500 CR500 6 minutes ago
70,850,000
RDAR
DiamondHealer95 DiamondHealer95 6 minutes ago
Respectfully, I get what you're saying but there is a very specific standard to uplist and the alternatives are clearly listed in the post. I had the "conversation" with the "bot" and was very specific with my prompts, yes, I have a reasonable amount of training in using AI prompts. I'm confident
KBLB
Sammy boy Sammy boy 6 minutes ago
Check whale balls on NYCB board, a complete fool!
FNMA
ali g ali g 8 minutes ago
Me thinks we get a kick off soon bruvs, eegi up first
awesomed007 awesomed007 8 minutes ago
What date is Q4 earnings?
RDAR
12yearplan 12yearplan 8 minutes ago
Isn't trump into deregulation, less oversight, etc,.. good luck with your trades..
MrMike241 MrMike241 9 minutes ago
This 💯
https://youtu.be/1-L_oSjy-_s?si=ggPQ9-FnJygB4u3Q
1jas 1jas 9 minutes ago
Where would the money come from to acquire Mingothings.? Dell,? since they are partners.? Affu's delusion could have come from the declining PPS the further the PPS dropped the more Affu delusion was needed to pay for all expenses.
AFFU
oldstocks oldstocks 10 minutes ago
Digital Spain 2025
https://portal.mineco.gob.es/RecursosArticulo/mineco/ministerio/ficheros/210204_Digital_Spain_2025.pdf
AFFU
cojoboy cojoboy 11 minutes ago
Bubba post your paste and shack
RDAR
stealofadeal stealofadeal 11 minutes ago
$GEVI Bro this company is moving forward with much potential. This S-1 will help grow the company.
GEVI
oldstocks oldstocks 11 minutes ago
I am focusing on OneMind Technologies and Mingothings are Spanish Companies.

Spain Digital Transformation 2025 refers to a government initiative aimed at significantly advancing Spain's digital economy by 2025, encompassing measures to promote widespread adoption of digital technologi
AFFU
cjstocksup cjstocksup 11 minutes ago
She is horrible. She is 1 of 5 on the panel on The Five. Great show but she is horrible. We all hate her. Most Fox news shows are the best if you know what to watch. The rest of that panel makes it worth watching. Greg Gutfeld, Jesse Watters, Judge Jeanine Pirro and Dana Perino.
Fox News Host
PantyPuller PantyPuller 12 minutes ago
I'll be watching tough guy..lol. such a clown
JNSH
HGilS HGilS 14 minutes ago
You lost me after « Ok love your spin on this and lots of things in the past… »

This is no fng sarcasm. This is heil to my king to me.
ELTP
12yearplan 12yearplan 16 minutes ago
Lol, .. just about time to sign off for all this good watchin'.. gnite 🙂
955 955 16 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/15/qeexqIllegalAliens.pnghttps://investorshub.advfn.com/uimage/uploads/2025/2/15/zoequIllegalAliensII.png
12yearplan 12yearplan 17 minutes ago
Catch you up.. [yt]mJ1NfTlg3Yk[/yt]

Your Recent History

NASDAQ
OCX
Oncocyte
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads